Risultati per: Diagnosi e gestione del glaucoma

Focus anche sul trattamento innovativo e riabilitativo

Araldi, ‘con MedMal Report identifichiamo aree più a rischio’

Objectives
To identify suitable patients for glaucoma home monitoring and explore clinicians’ perceptions of the possible benefits and risks of home monitoring within the National Health Service.

Design
An online survey composed of open-ended and closed-ended questions.

Setting
Secondary care.

Participants
Glaucoma specialists registered with the UK and Eire Glaucoma Society.

Outcome measures
Agreement with clinical scenarios.

Results
The estimated response rate was 68% (n=49). Of 49 participants, 92% (n=45) were consultant ophthalmologists and 71% (n=35) had over 10-year experience. There was a poor agreement regarding an ideal glaucoma patient for home monitoring, with only one scenario achieving over 60% agreement. Most participants believed that home monitoring would be most suitable for low-risk scenarios, rather than high-risk, due to fear of missing progression. In relation to acceptability, key facilitators included the potential to increase healthcare capacity and promote patient safety. However, low clinician trust in equipment reliability and fear of patient harm were reported as concerns.

Conclusions
There was no clear consensus on which patients would benefit most from glaucoma home monitoring. While many clinicians believe home monitoring may enhance healthcare, there were also many concerns about the technologies themselves. Further work to address clinician concerns is warranted.

Research Registry registration number
6213.

I moderni dispositivi permettono di adattare la terapia insulinica alle esigenze individuali di ciascun paziente, migliorando l’efficacia del trattamento

La gran parte degli accessi al PS legata ai sintomi del cancro